Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Weimar

Showing results (221-230 of 436) with videos related to

Pageof 44
Sort By:
Clinical and Experimental Medicine|July 5, 2007
Decreased antigen-specific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysisM A Verkade, C J van Druningen, C T Op de Hoek, et al.
Acta Orthopaedica Scandinavica|October 1, 1985
Incidence of osteonecrosis after renal transplantationH J Metselaar, E J van Steenberge, A B Bijnen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 1998
Cytomegalovirus colitis in a CMV-seropositive renal transplant recipient on triple drug therapy (including mycophenolate)P J Smak Gregoor, T van Gelder, A Abraham Tanis, et al.
Clinical and Experimental Immunology|April 7, 1998
The frequency and avidity of committed cytotoxic T lymphocytes (cCTL) for donor HLA class I and class II antigens and their relation with graft vascular diseaseN M van Besouw, E H Loonen, L M Vaessen, et al.
Journal of Medical Virology|May 1, 1986
Mononuclear subsets during cytomegalovirus disease in renal transplant recipients treated with cyclosporine and rabbit antithymocyte globulinH J Metselaar, P H Rothbarth, G J Wenting, et al.
Human Gene Therapy|July 8, 2011
Immunological aspects of allogeneic and autologous mesenchymal stem cell therapiesM J Hoogduijn, M Roemeling-van Rhijn, S S Korevaar, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 25, 2004
[Cross-over transplantation; a new national program for living kidney donations]M de Klerk, J N Ijzermans, L W Kranenburg, et al.
Clinical Nephrology|January 1, 1995
Optimising glomerular filtration rate and effective renal plasma flow measurements using a simple pharmacokinetic modelR Zietse, P J Blankestijn, B Pos, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 1997
Cytotoxicity of graft-derived lymphocytes: specific for donor heart endothelial cells?N H Jutte, C J Knoop, P Heijse, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 14, 2013
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†)R Bouamar, N Shuker, D A Hesselink, et al.
Pageof 44

Showing results (221-230 of 436) with videos related to

Sort By:
Pageof 44
Clinical and Experimental Medicine|July 5, 2007
Decreased antigen-specific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysisM A Verkade, C J van Druningen, C T Op de Hoek, et al.
Acta Orthopaedica Scandinavica|October 1, 1985
Incidence of osteonecrosis after renal transplantationH J Metselaar, E J van Steenberge, A B Bijnen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 1998
Cytomegalovirus colitis in a CMV-seropositive renal transplant recipient on triple drug therapy (including mycophenolate)P J Smak Gregoor, T van Gelder, A Abraham Tanis, et al.
Clinical and Experimental Immunology|April 7, 1998
The frequency and avidity of committed cytotoxic T lymphocytes (cCTL) for donor HLA class I and class II antigens and their relation with graft vascular diseaseN M van Besouw, E H Loonen, L M Vaessen, et al.
Journal of Medical Virology|May 1, 1986
Mononuclear subsets during cytomegalovirus disease in renal transplant recipients treated with cyclosporine and rabbit antithymocyte globulinH J Metselaar, P H Rothbarth, G J Wenting, et al.
Human Gene Therapy|July 8, 2011
Immunological aspects of allogeneic and autologous mesenchymal stem cell therapiesM J Hoogduijn, M Roemeling-van Rhijn, S S Korevaar, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 25, 2004
[Cross-over transplantation; a new national program for living kidney donations]M de Klerk, J N Ijzermans, L W Kranenburg, et al.
Clinical Nephrology|January 1, 1995
Optimising glomerular filtration rate and effective renal plasma flow measurements using a simple pharmacokinetic modelR Zietse, P J Blankestijn, B Pos, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 1997
Cytotoxicity of graft-derived lymphocytes: specific for donor heart endothelial cells?N H Jutte, C J Knoop, P Heijse, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 14, 2013
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†)R Bouamar, N Shuker, D A Hesselink, et al.
Pageof 44